SIBO, or small intestinal bacterial overgrowth, is a condition where abnormally large numbers of bacteria colonize the small intestine, a part of the gut that normally contains relatively few. These bacteria ferment food that should be absorbed by your body, producing gas and triggering digestive symptoms like bloating, diarrhea, and abdominal pain. It’s both more common and more complicated than many people realize, with high recurrence rates and overlapping symptoms with other gut conditions.
How SIBO Develops
Your body has several built-in defenses that keep bacterial counts low in the small intestine. Stomach acid kills most bacteria you swallow with food. Bile acids and digestive enzymes break down and degrade bacteria further along. Your immune system produces antibodies in the gut lining that prevent bacterial proliferation. And perhaps most importantly, rhythmic muscular contractions called the migrating motor complex sweep residual bacteria and debris out of the small intestine between meals, like a cleaning wave that resets the gut every 90 to 120 minutes.
SIBO develops when one or more of these defenses breaks down. The ileocecal valve, a one-way door between the small and large intestine, normally prevents colon bacteria from migrating backward. When motility slows or the valve doesn’t function properly, colonic bacteria can creep into the small intestine and establish themselves there. Once established, these bacteria feed on the carbohydrates passing through, producing hydrogen gas and other byproducts that cause symptoms.
Common Causes and Risk Factors
Anything that slows gut motility or reduces stomach acid raises SIBO risk. The connection between impaired motility and bacterial overgrowth was first described decades ago, and subsequent research has confirmed that people with SIBO tend to have fewer and shorter cleaning waves in the small intestine compared to healthy individuals.
Specific risk factors include:
- Conditions that slow motility: diabetes (which can damage gut nerves), hypothyroidism, scleroderma, and prior abdominal surgery
- Low stomach acid: chronic use of acid-suppressing medications (proton pump inhibitors) is significantly associated with SIBO recurrence
- Structural changes: prior appendectomy, small bowel adhesions, diverticulosis of the small intestine, or surgical alterations like gastric bypass
- Older age: motility naturally slows with age, and older adults face higher recurrence rates after treatment
Symptoms and Nutritional Effects
The hallmark symptoms are bloating, abdominal distension, and excessive gas, often within an hour or two of eating. Depending on the type of overgrowth (more on that below), you may experience diarrhea, constipation, or both. Abdominal pain and cramping are common, and symptoms frequently overlap with irritable bowel syndrome. In fact, a significant subset of people diagnosed with IBS actually have underlying SIBO.
Beyond digestive discomfort, SIBO can quietly cause nutritional deficiencies. The overgrown bacteria compete with your body for vitamin B12, consuming it before you can absorb it. They also break apart bile acids in the upper small intestine, which disrupts your ability to absorb dietary fat. Without proper fat absorption, fat-soluble vitamins (A, D, and E) can’t be taken up efficiently either. Over time, this can lead to anemia, low vitamin D, unintentional weight loss, and low protein levels.
SIBO vs. Intestinal Methanogen Overgrowth
Not all overgrowth involves bacteria. A related condition called intestinal methanogen overgrowth (IMO) is caused by archaea, single-celled organisms that belong to an entirely different biological domain than bacteria. The dominant species involved is Methanobrevibacter smithii, which doesn’t ferment carbohydrates directly. Instead, it consumes the hydrogen gas produced by other microbes and converts it into methane.
This distinction matters because the symptoms differ. Hydrogen-producing bacterial overgrowth tends to cause diarrhea and is linked to diarrhea-predominant IBS. Methane-producing archaea slow intestinal transit, so IMO is more closely associated with constipation, bloating, and abdominal discomfort. The treatment approach also differs, which is why clinicians now recognize IMO as a separate condition rather than a subtype of SIBO.
How SIBO Is Diagnosed
The most widely used test is a breath test. You drink a sugar solution (either glucose or lactulose) after an overnight fast, then breathe into collection tubes at regular intervals over two to three hours. The bacteria in your small intestine ferment the sugar and produce gases that are absorbed into your bloodstream and exhaled through your lungs.
A positive result for hydrogen-dominant SIBO requires a rise in exhaled hydrogen of at least 20 parts per million above your baseline within 90 minutes of drinking the solution. For methane, a concentration of 10 parts per million or higher at any point during the test indicates methanogen overgrowth. The test is noninvasive and can be done at a clinic or at home with a kit.
The other diagnostic option is a small bowel aspirate, where fluid is collected directly from the small intestine during an endoscopy and cultured for bacteria. This is more invasive and less commonly used, but it provides direct evidence. The traditional threshold was 100,000 colony-forming units per milliliter of fluid, though a more recent consensus has lowered it to 1,000 colony-forming units per milliliter of coliform bacteria. IMO can only be diagnosed by breath testing, not by aspirate culture.
Treatment Options
The primary treatment for SIBO is a course of antibiotics. For hydrogen-dominant SIBO, the most commonly prescribed antibiotic works locally in the gut with minimal absorption into the bloodstream, which limits side effects. A typical course lasts 7 to 14 days, though treatment duration can range from 5 to 28 days depending on severity and response. Methane-dominant overgrowth is generally harder to eradicate and often requires a combination of two antibiotics taken together.
Some practitioners use herbal antimicrobials as an alternative, though the evidence base is smaller. Dietary changes, particularly reducing fermentable carbohydrates, can help manage symptoms during and after treatment but don’t typically resolve the overgrowth on their own.
Why SIBO Often Comes Back
Recurrence is one of the most frustrating aspects of SIBO. In one study tracking 80 patients after successful antibiotic treatment, about 13% tested positive again at 3 months, 28% at 6 months, and 44% at 9 months. That’s nearly half of successfully treated patients relapsing within less than a year.
The recurrence rate is high because antibiotics kill the excess bacteria but don’t fix the underlying reason the overgrowth happened. If your motility is impaired, your stomach acid is suppressed, or you have structural changes from surgery, the conditions that allowed SIBO to develop are still present after treatment ends. Older age, a history of appendectomy, and chronic use of acid-suppressing medications were all independently associated with higher recurrence risk in that same study.
To break the cycle, some clinicians prescribe low-dose prokinetic agents at bedtime. These medications stimulate the migrating motor complex during sleep, essentially restoring the cleaning waves that keep the small intestine clear. A low dose of the antibiotic erythromycin (used here for its motility effects, not its antibacterial properties) taken at night has been shown to significantly delay symptom recurrence. Addressing reversible risk factors, like tapering off acid-suppressing medications when possible, also plays a role in long-term management.